Stock message boards
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

ACOR Crosses Above Key Moving Average Level
Tuesday, March 24, 12:01 PM ET, by Market News Video Staff

In trading on Tuesday, shares of Acorda Therapeutics Inc (ACOR) crossed above their 200 day ...

First Week of May 15th Options Trading For Bruker (BRKR)
Wednesday, March 25, 12:18 PM ET, by Market News Video Staff

Investors in Bruker Corp (BRKR) saw new options become available this week, for the May ...

Relative Strength Alert For MannKind
Wednesday, March 25, 12:25 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

ALXN Makes Notable Cross Below Critical Moving Average
Wednesday, March 25, 4:42 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Alexion Pharmaceuticals Inc. (ALXN) crossed below their 200 day ...

Use Options For a Chance To Buy BMRN at a 28% Discount
Thursday, March 26, 11:42 AM ET, by Market News Video Staff

Looking back to 63 days ago, BioMarin Pharmaceutical Inc. (BMRN) priced a 8,500,000 share secondary ...

  More articles:  1 2 3 4 5 6 7 next »

Bruker Corp Breaks Below 200-Day Moving Average - Notable for BRKR

By Market News Video Staff, Thursday, November 29, 12:17 PM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Thursday, shares of Bruker Corp (NASDAQ:BRKR) crossed below their 200 day moving average of $13.96, changing hands as low as $13.88 per share. Bruker Corp shares are currently trading up about 1% on the day. The chart below shows the one year performance of BRKR shares, versus its 200 day moving average:

Bruker Corp 200 Day Moving Average Chart

Looking at the chart above, BRKR's low point in its 52 week range is $9.91 per share, with $17.10 as the 52 week high point that compares with a last trade of $14.55.

Special Offer: Manage the risks of the markets better with a free 30 day trial to the Strategic Risk Management System.

According to the ETF Finder at ETF Channel, BRKR makes up 3.32% of the Dynamic Biotechnology & Genome Portfolio ETF (AMEX:PBE) which is trading up by about 0.9% on the day Thursday.

See what other ETFs contain BRKR
See what other stocks are held by PBE

Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AMEX   According   BRKR   Bruker   Corp   Crossing   Definition   Definitions   ETFs   Earnings   Exchange   Finder   Fund   Genome   Looking   Management   Price   Special   Start   Stocks   Strategic   Their   Thursday   Traded   about   average   below   better   changing   chart   compares   currently   held   last   makes   markets   moving   other   point   range   raquo   share   shares   that   trading   versus   week   what   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

Bruker Corp Breaks Below 200-Day Moving Average - Notable for BRKR | Market News Video | Copyright © 2008 - 2015, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.